Clinical outcomes of retrievable inferior vena cava filters for venous thromboembolic diseases

J Comp Eff Res. 2022 Apr;11(6):437-449. doi: 10.2217/cer-2021-0291. Epub 2022 Feb 24.

Abstract

Aim: To identify literature evidence assessing retrievable inferior vena cava filter (rIVCF) for venous thromboembolic diseases. Methods: A systematic literature search was conducted to identify relevant references from the mainstay English and Chinese bibliographic databases (search period: January 2003 to October 2019). Results: 80 original studies with 11,413 patients were included in this review. The success rates of deploying the six types of rIVCFs ranged from 98.4 to 100.0%. Denali had the highest retrieval success rate (95.4-97.6%). The incidence rates of fracture and perforation associated with retrieving the six rIVCFs were less than 2%. Conclusion: The approved rIVCF had comparable clinical profiles, except that Denali was easier to be retrieved than other rIVCF.

Keywords: complication; meta-analysis; pulmonary embolism; retrievable inferior vena cava filter; venous thromboembolic diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Device Removal
  • Humans
  • Incidence
  • Retrospective Studies
  • Treatment Outcome
  • Vena Cava Filters*
  • Venous Thrombosis*